
Instgra 50mg Tablet
Salt Composition: Dolutegravir
Expiry Date: 01/2028
Inclusive of all taxes
30 tablets

Instgra 50mg Tablet
30 tablets
Dolutegravir
Salt Composition
Dolutegravir
Storage
Below 25°C
Expiry Date
01/2028
Marketer
emcure
Brand
instgra

Naivex 50mg Tablet
30 tablet
Dolutegravir
Salt Composition
Dolutegravir
Storage
Below 25°C
Expiry Date
01/2028
Marketer
Hetero
Brand
naivex
5966.png&w=1920&q=75)
MAGIC DEALS
Buy at $37.94
Apply Promo Code
Available CouponsInstgra 50mg Tablet
Inclusive of all taxes
In Stock
Authorized
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
HIV infection
- The contents of Instgra 50 mg include dolutegravir, which acts as an antiretroviral agent.
- It is used in the treatment of patients infected with HIV, in both adult and child patients weighing 14-20 kg.
- As an integrase inhibitor, this drug inhibits the replication of the virus within the body, hence reducing its concentration while increasing the count of CD4 cells to enhance the immune system of the patient.
- It is important to note that this drug does not offer a cure for the infection; rather, it is essential in the prolonged treatment process and is usually administered either once or twice a day, regardless of whether food was taken or not.
- Consistency in the intake of this drug is crucial, since missing any doses might make the medication less effective, leading to resistance.
- The intake of antacids or calcium supplements should also be avoided around the period of administration of the drug due to possible interactions.
Uses
HIV infection
Side Effects of Instgra 50mg Tablet
The following are the possible side effects that can occur during your treatment with Instgra 50mg Tablet. Contact your medical practitioner immediately if any of the below-mentioned side effects appear.
- Nausea
- Fatigue / tiredness
- Muscle pain / cramps
- Joint pain
- Headache
- Rash / itching
- Abnormal dreams
- Insomnia
- Anxiety
- Depression
- Dizziness
- Stomach pain / discomfort
- Diarrhea
- Weight gain
- Edema / swelling (face, legs, ankles, feet, body)
- Allergic reactions (swelling, fever)
- Infections / inflammation
- Fever
- Lack of sleep
- Increased liver enzymes
- Liver inflammation / liver failure
- Decreased red and white blood cell counts
- Heart failure
- Gastrointestinal disorders
- Hypothyroidism
Dosage and Administration
- This is an oral prescription medicine.
- The dose and period of treatment using the medicine will depend on various aspects of your condition, which will be determined by your physician.
- Always use Instgra 50mg Tablet according to your physician’s prescription.
- You can swallow the tablet either with or without food.
- Ensure that you do not crush, bite, or chew the tablet.
Mechanism of action
- Instgra 50mg Tablet, comprising Dolutegravir, is an HIV-1 antiviral agent.
- It works to inhibit HIV integrase and binds to the active site. It blocks the strand transfer step of retroviral DNA integration in the host cell.
- During the clinical trials, it was indicated that Dolutegravir has a tight binding and longer dissociative half-life.
- Therefore, it is indicated in combination with other antiretroviral agents for the treatment of patients with HIV-1 infection, provided their age is 12 or above and their present weight is at least 40 kg.
Safety Advice
Missed Doses
- If you miss a dose, it is advisable to consult your healthcare provider to get the needed help.
- Also, make sure to not double the dose strength to catch up.
FAQs
Instgra (Dolutegravir 50mg) tablet prescribed for the treatment of HIV (Human Immunodeficiency Virus) infection.
References
Dravid, P., Elica K., Sharma, S., Gupta, A., Roy, A., Basu, S., Singh, S. (2022). A Phase IV study on safety, Tolerability, and efficacy of dolutegravir, lamivudine, and tenofovir disoproxil fumarate in treatment‑naïve adult Indian patients living with HIV‑1. Clinical Infectious Diseases.Published online
Marchand, C. (2012). The elvitegravir Quad pill: the first once-daily dual-target anti-HIV tablet. Expert opinion on investigational drugs, 21(7), 901-904. Gandhi Medicos. (2024). Navigating HIV management with Instgra Tablet: What you need to know. Gandhi Medicos Blog. Retrieved from
Panel on Antiretroviral Guidelines for Adults and Adolescents. (2024). Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services Services. Retrieved from
Dravid, A., Morkar, D., Prasad, D., Ramapuram, J. T., Patel, K. V., Naik, K. S., Hegde, S. (2022). A phase IV study on safety, tolerability, and efficacy of dolutegravir, lamivudine, and tenofovir disoproxil fumarate in treatment-naïve adult Indian patients living with HIV-1. Pragmatic and Observational Research, 13, 75–84.
Walmsley, S. L., Antela, A., Clumeck, N., Duiculescu, D., Eberhard, A., Gutiérrez, F., … Schapiro, J. M. (2013). Dolutegravir plus abacavir–lamivudine for the treatment of HIV-1 infection. New England Journal of Medicine, 369(19), 1807–1818
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)